Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes fo...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

_ProfessorGamma Jul. 28 at 11:24 PM

$HCAI $CRIS $BANL $SKK $FFAI ~~~

0 · Reply

_ProfessorGamma Jul. 28 at 7:31 PM

$MTEX $MSAI $SGLY $CRIS $BANL clocking

0 · Reply

IN0V8 Jul. 24 at 1:55 PM

$CRIS Opportunity / Watch H.C. Wainwright raises target price to $43 from $17

1 · Reply

Merlintrader Jul. 22 at 5:15 PM

$BBIO Biotech Radar July 22, 2026: $BBIO, $CRIS, $MNPR and Others https://www.merlintrader.com/biotech-radar-july22/

0 · Reply

KUMO2026 Jul. 22 at 1:38 PM

$CRIS short off algo trap 5.50

0 · Reply

topstockalerts Jul. 22 at 1:31 PM

Pre Market Top Gainers PT2 $ADVB $KUST $ARWR $CRIS $FNWD

0 · Reply

MadStockAlerts1 Jul. 22 at 1:18 PM

Premarket top gainers (1/2) $INLF +44.8% ($3.23) INLF $ZCMD +25.9% ($1.85) ZCMD $CRIS +18.7% ($5.64) CRIS $ADVB +18.1% ($8.36) ADVB $ARWR +17.7% ($87.69) ARWR

0 · Reply

Unburdened Jul. 22 at 12:56 PM

$CRIS This should be up 50% on these results. About time they had something positive to say rather than dilute shareholders all the time.

2 · Reply

Stock_Catcher Jul. 22 at 12:53 PM

$CRIS Curis Announces Positive Emavusertib Update

0 · Reply

BuyLongHoldStrong Jul. 22 at 12:27 PM

$LABT $CRIS Could go hard soon as well once results are announced today. Not advice

1 · Reply

Curis price target raised to $43 from $17 at H.C. Wainwright

Jul 22, 2026, 8:30 AM EDT - 6 days ago

Curis Transcript: Study update

Jul 22, 2026, 8:30 AM EDT - 6 days ago

Curis Press release: Study update

Jul 22, 2026, 8:30 AM EDT - 6 days ago

Curis Slides: Study update

2026-07-22T11:05:25.000Z - 6 days ago

Curis to report clinical data in the TakeAim Lymphoma study

Jul 22, 2026, 7:00 AM EDT - 6 days ago

Curis Announces Positive Emavusertib Update

Jul 15, 2026, 7:00 AM EDT - 13 days ago

Curis Slides: Corporate presentation

2026-07-06T13:35:18.000Z - 22 days ago

Curis consents first six patients in TakeAim CLL study

Jul 6, 2026, 9:30 AM EDT - 22 days ago

Curis Consents First Six Patients in TakeAim CLL Study

2026-07-02T23:50:20.000Z - 26 days ago

Curis trading halted, news pending

2026-06-26T13:50:10.000Z - 4 weeks ago

Curis announces eleven active clinical sites in TakeAim CLL study

Jun 26, 2026, 9:42 AM EDT - 4 weeks ago

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

Jun 25, 2026, 11:00 AM EDT - 4 weeks ago

Curis Transcript: EGM 2026

Jun 5, 2026, 8:00 AM EDT - 7 weeks ago

Curis Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 7 weeks ago

Curis Slides: Corporate presentation

May 22, 2026, 8:00 AM EDT - 2 months ago

Curis Proxy statement: Proxy filing

May 19, 2026, 11:00 AM EDT - 2 months ago

Curis Transcript: AGM 2026

2026-05-12T22:10:48.000Z - 2 months ago

Curis reports Q1 EPS ($1.25), consensus (29c)

2026-05-12T22:07:01.000Z - 2 months ago

Curis sees cash and proceeds enough for operations into second half of FY27

May 12, 2026, 4:30 PM EDT - 2 months ago

Curis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Curis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Curis Quarterly report: Q1 2026

May 12, 2026, 4:00 PM EDT - 2 months ago

Curis Provides First Quarter 2026 Business Update

May 5, 2026, 5:11 PM EDT - 3 months ago

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Curis Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Curis Proxy statement: Proxy filing

Mar 30, 2026, 7:00 AM EDT - 4 months ago

Curis Slides: Corporate presentation

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Curis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Curis Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Curis Earnings release: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 4 months ago

Curis Provides Fourth Quarter 2025 Business Update

Mar 17, 2026, 11:00 AM EDT - 4 months ago

Curis Transcript: EGM 2026

Mar 12, 2026, 4:27 PM EDT - 4 months ago

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

Feb 19, 2026, 7:00 AM EST - 5 months ago

Curis Proxy statement: Proxy Filing

Feb 13, 2026, 7:00 AM EST - 5 months ago

Curis Registration statement: Registration Filing

Feb 9, 2026, 7:00 AM EST - 6 months ago

Curis Proxy statement: Proxy Filing

Jan 9, 2026, 8:00 AM EST - 7 months ago

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Jan 7, 2026, 8:45 AM EST - 7 months ago

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Dec 9, 2025, 8:00 AM EST - 8 months ago

Curis Provides Updated Data from its Frontline AML Triplet Study

Nov 14, 2025, 9:26 AM EST - 9 months ago

Curis to Present at Upcoming 30th Annual SNO Meeting

Nov 6, 2025, 4:30 PM EST - 9 months ago

Curis Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Curis Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Curis Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 9 months ago

Curis Provides Third Quarter 2025 Business Update

Oct 30, 2025, 4:00 PM EDT - 9 months ago

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Oct 3, 2025, 4:00 PM EDT - 10 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 10, 2025, 10:00 AM EDT - 11 months ago

Curis Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 9:45 AM EDT - 11 months ago

Curis Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 10:43 AM EDT - 11 months ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 11, 2025, 8:00 AM EDT - 1 year ago

Curis Registration statement: Registration Filing

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Curis Quarterly report: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 1 year ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 1 year ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 7, 2025, 8:00 AM EDT - 1 year ago

Curis Registration statement: Registration Filing

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Apr 9, 2025, 4:30 PM EDT - 1 year ago

Curis Transcript: Jones Healthcare and Technology Innovation Conference 2025

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Annual report: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings release: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Proxy statement: Proxy Filing

Mar 28, 2025, 4:07 PM EDT - 1 year ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 23, 2024, 7:00 AM EST - 1 year ago

Curis Registration statement: Registration Filing

Dec 10, 2024, 8:00 AM EST - 1 year ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Quarterly report: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 1 year ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 2 years ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 3:05 PM EDT - 2 years ago

Curis Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2024, 7:30 AM EDT - 2 years ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2024, 1:00 PM EDT - 2 years ago

Curis Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q2 2024

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 2 years ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conference in July

May 14, 2024, 4:30 PM EDT - 2 years ago

Curis Transcript: Status Update

May 10, 2024, 8:00 AM EDT - 2 years ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Apr 8, 2024, 12:45 PM EDT - 2 years ago

Curis Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 5, 2024, 7:00 AM EDT - 2 years ago

Curis Slides: Corporate Presentation

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conferences in April

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Curis Proxy statement: Proxy Filing

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Annual report: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings release: Q4 2023

Feb 8, 2024, 8:00 AM EST - 2 years ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 8, 2024, 7:00 AM EST - 2 years ago

Curis Registration statement: Registration Filing

Feb 1, 2024, 8:00 AM EST - 2 years ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 2 years ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 2 years ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 2 years ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Quarterly report: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Earnings release: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 2 years ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 3 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 18, 2023, 8:00 AM EDT - 3 years ago

Curis Proxy statement: Proxy Filing

Aug 4, 2023, 8:00 AM EDT - 3 years ago

Curis Proxy statement: Proxy Filing

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Quarterly report: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings release: Q2 2023

Aug 3, 2023, 4:01 PM EDT - 3 years ago

Curis Provides Second Quarter 2023 Business Update

Jul 27, 2023, 6:25 PM EDT - 3 years ago

Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023

Jul 6, 2023, 8:01 AM EDT - 3 years ago

FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID

_ProfessorGamma Jul. 28 at 11:24 PM

$HCAI $CRIS $BANL $SKK $FFAI ~~~

0 · Reply

_ProfessorGamma Jul. 28 at 7:31 PM

$MTEX $MSAI $SGLY $CRIS $BANL clocking

0 · Reply

IN0V8 Jul. 24 at 1:55 PM

$CRIS Opportunity / Watch H.C. Wainwright raises target price to $43 from $17

1 · Reply

Merlintrader Jul. 22 at 5:15 PM

$BBIO Biotech Radar July 22, 2026: $BBIO, $CRIS, $MNPR and Others https://www.merlintrader.com/biotech-radar-july22/

0 · Reply

KUMO2026 Jul. 22 at 1:38 PM

$CRIS short off algo trap 5.50

0 · Reply

topstockalerts Jul. 22 at 1:31 PM

Pre Market Top Gainers PT2 $ADVB $KUST $ARWR $CRIS $FNWD

0 · Reply

MadStockAlerts1 Jul. 22 at 1:18 PM

Premarket top gainers (1/2) $INLF +44.8% ($3.23) INLF $ZCMD +25.9% ($1.85) ZCMD $CRIS +18.7% ($5.64) CRIS $ADVB +18.1% ($8.36) ADVB $ARWR +17.7% ($87.69) ARWR

0 · Reply

Unburdened Jul. 22 at 12:56 PM

$CRIS This should be up 50% on these results. About time they had something positive to say rather than dilute shareholders all the time.

2 · Reply

Stock_Catcher Jul. 22 at 12:53 PM

$CRIS Curis Announces Positive Emavusertib Update

0 · Reply

BuyLongHoldStrong Jul. 22 at 12:27 PM

$LABT $CRIS Could go hard soon as well once results are announced today. Not advice

1 · Reply

Stock_Catcher Jul. 22 at 12:16 PM

$CRIS thin

0 · Reply

BallWasher69 Jul. 22 at 12:12 PM

$CRIS best press release we’ve received in close to 2 years . There is still hope 🙏

0 · Reply

LodiDodiWeLikesToParty Jul. 16 at 1:17 AM

$CRIS mine is $1600

1 · Reply

UCD_12dd Jul. 15 at 1:41 AM

$CRIS can’t wait to part of the class action. My break even is now 209

1 · Reply

Unburdened Jul. 13 at 12:28 PM

$CRIS Absolute dog Sh$& management team. What a scam they have pulled off for 10+ years.

0 · Reply

alien7180 Jul. 10 at 3:33 PM

$CRIS $CRIS I’m in today. If the company completes dosing 5 patients by end of July 2026 it triggers $20M trench. Plus it is a low float.

0 · Reply

BirdOnAWire Jul. 8 at 7:59 AM

$CRIS Come pick me up at 253.

0 · Reply

Zaksab Jul. 7 at 4:26 PM

$CRIS hunch is this is a hold your nose type lovely buying opportunity

0 · Reply

TwongStocks Jul. 6 at 8:31 PM

Today's NASDAQ reverse split results. 7 of 10 closed green. Part 1 of 2: $ABTC 1 for 15 Previous close $0.5617, $8.4255 split-adjusted Today's high $9.33 Today's close $8.49 🟢Up 0.77% $CRIS 1 for 20 Previous close $0.3466, $6.932 split-adjusted Today's high $6.74 Today's close $5.94 🔴Down 14.31% $HKIT 1 for 25 Previous close $0.1650, $4.125 split-adjusted Today's high $5.26 Today's close $4.28 🟢Up 3.76% $INLF 1 for 200 Previous close $0.0216, $4.32 split-adjusted Today's high $9.91 Today's close $6.38 🟢Up 47.69% $JZ 1 for 30 Previous close $0.0970, $2.91 split-adjusted Today's high $3.60 (premarket) Today's close $2.99 🟢Up 2.75%

0 · Reply

Superdividend Jul. 6 at 7:59 PM

$CRIS we return back to 1$, AS USUAL! But with less shares in our portfolio

1 · Reply

focafoca99 Jul. 6 at 1:45 PM

$CRIS consented its first six patients in the TakeAim CLL study, marking a key enrollment milestone.

0 · Reply

KingsPlay92 Jul. 6 at 12:06 PM

$ABTC $CRIS $HKIT $INLF $JZ

0 · Reply

Market Cap	9.14M
Revenue (ttm)	9.44M
Net Income (ttm)	-7.58M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-80.30%
Debt to Equity Ratio	0.00

Volume	26,800
Avg Vol	215,272
Day's Range	N/A - N/A
Shares Out	1.95M
Stochastic %K	41%
Beta	3.08
Analysts	Strong Sell
Price Target	$43.00